Used in research settings to detect and quantify ischemia-modified albumin in mouse models, this ELISA kit enables the study of early ischemic events, particularly in cardiac and cerebral tissues. It supports investigations into the mechanisms of ischemia-reperfusion injury, evaluation of potential therapeutic interventions, and assessment of oxidative stress in experimental disease models. The kit is especially valuable in preclinical studies focusing on myocardial infarction, stroke, and other conditions involving tissue hypoxia, providing a sensitive tool for monitoring biochemical changes associated with ischemia.